Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7 by Kamradt, M C et al.
Over 95% of all cases of cervical carcinoma have been associated
with the human papillomavirus (HPV), especially high risk types
16 and 18 (for review, see Lazo, 1999; Walbloomers et al, 1999).
Papillomaviruses possess a double-stranded, circular DNA
genome which contains viral early (E1–E7) and late (L1–L2)
genes which are separated by a transcriptional control region, the
upstream regulatory region (URR) (reviewed in Hoppe-Seyler and
Butz, 1994). The HPV URR is directly upstream of the E6 and E7
genes, both of which have been shown to possess transforming
growth potential in vitro, most likely by direct interference with
p53 and retinoblastoma (Rb) (Werness et al, 1990). The tumour
suppressor proteins p53 and Rb are both regulators of cell cycle
progression. p53 mediates a G1/S checkpoint through transactiva-
tion of the p21 (WAF1/CIP1) gene, a cyclin-dependent kinase
inhibitor (el-Deiry et al, 1993; Harper et al, 1993), while Rb
sequesters E2F, a transcription factor responsible for transcription
of genes essential for cell cycle progression (reviewed in Almasan
et al, 1995). HPV E7 binds to the transcription factor binding
pocket in Rb, thereby displacing E2F which promotes cell cycle
progression through transactivation of target genes (Dyson et al,
1989). High-risk HPV E6 can abolish p53 function by seques-
tering p53 which inhibits its ability to bind DNA (Werness et al,
1990; Lechner and Laimins, 1994; Thomas et al, 1995) or E6 can
target p53 for ubiquitin-dependent proteolysis (Scheffner et al,
1990; Band et al, 1991; Crook et al, 1991; Demers, et al, 1994).
However, it has been shown that the presence of E6 in cervical
cancer cell lines is not functionally equivalent to a loss of p53 by
mutation or deletion. In contrast, despite the presence of E6 in
HPV-infected cervical carcinoma cells, p53 is inducible and can
activate the p53 target genes p21 and GADD45 in response to
DNA damaging agents (Butz et al, 1995, 1996, 1999).
The URR of the HPV genome contains an enhancer region
which is controlled by glucocorticoid response elements (GREs)
(Gloss et al, 1991). Glucocorticoids, specifically dexamethasone,
have been shown to activate the GRE of the HPV genome which
increases transcription of E6/E7 in most cervical carcinoma cells,
resulting in enhanced cell proliferation (Von Knebel Doeberitz
et al, 1988). This increase in transcription has been shown in C4-1
cells where dexamethasone increases cell proliferation and tumori-
genicity in nude mice, even though this does not occur in all
cervical cancer cell lines, such as HeLa (Von Knebel Doeberitz
et al, 1991, 1992). These effects have been interpreted as a conse-
quence of the perturbation in p53 and Rb function when bound to
E6 and E7 proteins. In contrast, transcription of HPV E6/E7 is
blocked by dexamethasone in the SW756 cell line resulting in
increased p53 levels and loss of the neoplastic phenotype of these
cells (Von Knebel Doeberitz et al, 1994).
While dexamethasone has been shown to modulate cellular
proliferation and tumorigenicity through increased transcription of
E6/E7 and subsequent effects on p53 and Rb, the effect of gluco-
corticoids on apoptosis in cervical carcinoma cell lines has not
been determined. However, studies have shown that E6 or E6/E7
can abrogate apoptosis in various cell systems (Pan and Griep,
1994; Puthenveettil et al, 1996; Thomas et al, 1996). Therefore, it
was of interest to determine the effect of dexamethasone on apop-
tosis in HPV-transformed cells in comparison to cells in which
E6/E7 are artificially overexpressed through transgenic or vector-
mediated genetic manipulation. Since p53 plays an important role
in the induction of apoptosis, it is possible that in HPV-positive
cervical cancer cells, dexamethasone treatment increases E6/E7,
thus compromising p53 function and leading to decreased
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cell line, dexamethasone decreased radiation-induced apoptosis,
an effect that correlates with increased transcription of E6/E7 and
subsequent reduction in levels of p53 protein and p21 mRNA. In
contrast, dexamethasone did not alter radiation-induced apoptosis
in cells in which HPV E6/E7 was repressed (SW756) or in cells
which lack the HPV genome (C33-a). Overall, glucocorticoids
decreased radiation-induced apoptosis only in cervical carcinoma
cells which displayed increased transcription of HPV E6/E7 genes
and decreased expression of p53.
MATERIALS AND METHODS
Cell culture
The human cervical carcinoma cell lines C4-1 and SW756 were
cultured in Dulbecco’s modified Eagle medium (DMEM; Sigma,
St Louis, MO, USA) supplemented with 4.5 g l–1 glucose and the
C33-a cells were grown in Eagle minimum essential medium
(EMEM; Sigma, St Louis, MO, USA). All media were supple-
mented with 4 mML -glutamine, 100 U ml–1 penicillin–strepto-
mycin, and 10% fetal calf serum (FCS; Biologos, Naperville, IL,
USA). All cultures were maintained in a 5% carbon dioxide (CO2)
atmosphere at 37°C. Cells were irradiated at 6 Gy using a dual
head Cs-137 Gammacell 40 irradiator (Nordion International,
Ontario, Canada). Dexamethasone (Decadron Phosphate, Merck,
Sharp and Dohme, West Point, PA, USA) was added to cultures at
a final concentration of 1 mM 30 min prior to irradiation.
Northern blot analysis
Total RNA was isolated by the TriZol method (Gibco-BRL). Cells
are scraped into the TriZol reagent which dissociates the nucleo-
protein complex. Samples were chloroform extracted and the
aqueous phase containing RNA was collected. RNA was precipi-
tated with isoamyl alcohol and pelleted. The RNA pellet was
washed with 75% ethanol, vacuum dried and dissolved in 100 ml
RNAase free, DEPC-treated water. RNA was quantitated by spec-
trophotometry and 10 mg was run on an agarose gel containing
formaldehyde. RNA was transferred to a nylon membrane (Bio-
Rad) which was then probed with a 32P radiolabelled cDNA probe
(see below) prepared using the Prime-a-Gene Kit (Promega)
according to the manufacturer’s instructions. The washed
membrane was exposed to X-ray film and developed using an
autoprocessor.
Preparation of the HPV 18 E6/E7 cDNA probe by PCR
In order to amplify the HPV-18 E6/E7 open reading frame,
primers utilized were generously donated by Dr Lutz Gissman.
The composition of these PCR primers was: E6/E7: 5¢-
ATGGCGCCCTTTGAGGATCC = nt 105–134; TTACT-
GCTGGGATGCACACC-3¢ = nt 907–888.
The E6/E7 probe was synthesized by polymerase chain reaction
(PCR) from a plasmid containing the entire HPV 18 genome
which was cloned into BlueScript at the HinDIII site. A 50 ml PCR
mix containing 20 mM Tris–HCl (pH 8.4), 50 mM potassium
chloride (KCl), 1.5 mM magnesium chloride (MgCl2), 0.2 mM E6-
E7 primers, 2 U Taq DNA polymerase and 2 ml cDNA from the
first strand synthesis reaction was made. Cycling was performed in
a Perkin-Elmer DNA Thermal Cycler 480 as follows: 94°C 1 min,
64°C 1.5 min, 72°C 3 min for 25 cycles. To ensure that the probe
was the appropriate size, PCR products were resolved by gel
electrophoresis on a 1% agarose gel and were visualized by
ethidium bromide staining.
Preparation of the p21 cDNA probe
The p21 cDNA probe was the generous gift of Dr Manuel Diaz.
The probe was labelled as described above.
Apoptotic determination
Morphology
Cells were treated with 1 mM dexamethasone, irradiated with 6 Gy
or treated with 1 mM dexamethasone for 30 min prior to irradia-
tion. Dexamethasone remained in the culture medium throughout
the experiment. Cells were treated on day 0 and collected to
determine the per cent apoptosis on days 1, 2 and 4. Cells were
trypsinized, washed in phosphate-buffered saline (PBS) and fixed
in 100% methanol. For morphological analysis, cells were stained
with propidium iodide (PI) and examined under the fluorescence
light microscope. Photographs were taken and at least 200 cells
were analysed for apoptotic morphology without knowledge of
treatment. Apoptotic cells are those with fragmented or condensed
nuclei, while live cells exhibit a round, intact nucleus.
Annexin staining
Annexin V binds to phosphatidylserine which is expressed on the
surface of cells undergoing apoptosis. The Annexin V fluorescein
isothiocyanate (FITC) kit was used according to the manufac-
turer’s instructions (Oncogene Science). Cells were analysed 96 h
post-irradiation and/or treatment with dexamethasone. Briefly, live
cells were collected by trypsinization and stained with FITC-
conjugated Annexin V and PI. Cells were then analysed by flow
cytometry (Becton Dickinson FACStar Plus) to determine the
percentage of Annexin-positive cells.
DNA fragmentation
Cells were treated as described for morphological analysis. At
least 2 ´ 106 cells were lysed in 500 ml lysis buffer (5 mM
Tris–HCl pH 7.4, 20 mM EDTA, 0.5% Triton X-100) at 4°C for 
2 h. Cell debris was removed by centrifugation at 30 000 g for 
30 min at 4°C. The supernatant was collected and treated with 
0.5 mg ml–1 RNAase at 50°C for 1 h, followed by 0.4 mg ml–1
proteinase K in 1% sodium dodecyl sulphate (SDS) at 50°C for 1
h. The DNA was then extracted with choloroform/isoamyl alcohol
(24:1) and precipitated overnight with 2.5 ´ the volume of 95%
ethanol. The DNA was dissolved in 10 ml TE (10 mM Tris–HCl,
pH 8.0, 1 mM EDTA) and subjected to gel electrophoresis on a 1%
agarose gel in 1 ´ TAE buffer. Gels were stained with ethidium
bromide, visualized by ultraviolet light and photographed using
Polaroid 57 film.
FACS analysis
Cells were treated as described above on day 0, collected at 12 h, 
1 day, 2 days and 4 days following treatment and fixed in 100%
cold methanol to permeablize the cells. Cells were washed in
PBS/0.25% BSA/0.1% NaN3 and incubated with either a mouse
anti-human p53 primary antibody (Oncogene Science, Ab6) or an
isotype-matched control antibody (IgG2a); both were used at a final
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room temperature. Ab6 binds to amino acids 37–45 on both
mutant and wild-type p53 proteins. Cells were washed and incu-
bated for 15 min at room temperature with a FITC-conjugated
rabbit anti-mouse IgG at a final concentration of 300 mg ml–1. Cells
were analysed by flow cytometry on a Becton Dickinson FACStar
Plus and the mean green fluorescence corresponding to p53
content was determined as the mean fluorescence of the test
sample minus that of control immunoglobulin. The specificity of
the p53 antibody (Oncogene Science, Ab6) was confirmed by
Western blot analysis.
Western blot
Protein was extracted from control cells, cells treated with 1 mM
dexamethasone and cells irradiated at 6 Gy in the presence or
absence of dexamethasone. Protein extraction was performed for
30 min on ice in RIPA buffer containing 250 mM NaCl, 50 mM
Tris, 0.1% Nonldet P-40, 0.1% SDS, 0.5% sodium deoxycholate
and the protease inhibitors leupeptin and phenyl methylsulphonyl
fluoride (PMSF). Proteins were quantitated using the BioRad
Detergent Compatible Protein Assay kit. Equal amounts of protein
(15–20 mg) were diluted in Laemmli buffer containing b-mercapto-
ethanol and resolved on a 10% minigel by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE). Proteins were then transferred to
a polyvinyl difluoride (PVDF) membrane (BioRad) using the
NOVEX system followed by immunoblotting using an antibody to
p53 (Oncogene Science Ab 6). The membrane was subsequently
developed using enhanced chemiluminescence (ECL, Amersham).
RESULTS
Dexamethasone alters E6/E7 mRNA
C4-1, SW756 and C33-a cells were irradiated with 6 Gy in the
presence or absence of 1 mM dexamethasone. Northern blot
analysis revealed that transcription of the HPV E6/E7 was
increased when C4-1 cells were treated with dexamethasone for 
48 h while E6/E7 mRNA levels decreased in the SW756 cells
(Figure 1A). C33a cells do not possess the HPV genome and were
therefore negative for expression of HPV E6/E7 mRNA as deter-
mined by Northern blot (data not shown). The E6/E7 mRNA
levels were normalized against the 18/28 S ribosomal RNA and
the standard error of the mean densitometric units are shown
(Figure 1B). It was determined that in comparison to control cells,
C4-1 cells treated with dexamethasone alone or in combination
with irradiation exhibited a five- to sevenfold induction of HPV
E6/E7 mRNA. In contrast, the dexamethasone-treated and dexam-
ethasone-treated plus irradiated SW756 cells showed a twofold
reduction in HPV E6/E7 mRNA in comparison to untreated cells.
Analysis of apoptosis
It has been shown that overexpression of E6 or E6/E7 results in
abrogation of apoptosis (Pan and Griep, 1994; Thomas et al, 1996;
Puthenveettil et al, 1997); however, these studies addressed the
effect of E6/E7 on programmed cell death utilizing transgenic
animals or cells that overexpress the viral genes through vector or
adenoviral-mediated transfection. In keratinocytes infected with
HPV, the viral genes E6/E7 are controlled by the same promoter;
therefore, it is important to understand the effect of simultaneous
manipulation of both E6 and E7. We hypothesized that up-regula-
tion of E6/E7 in response to dexamethasone would diminish the
potential for cervical cells to access apoptosis following g radia-
tion. Therefore, the effect of glucocorticoids on radiation-induced
apoptosis was determined as assessed by nuclear morphology and
Annexin V staining (Figure 2). The control, untreated cells
displayed homogeneously-stained DNA and a round, regularly
shaped nucleus.
Irradiated cells displayed condensed or fragmented nuclei, both
of which are hallmarks of apoptosis. The C4-1 cell line (in which
dexamethasone increases the HPV E6/E7 genes) showed a time-
dependent increase in the percent of apoptosis over a 4-day period
(Figure 2A) and the level of radiation-induced apoptosis was
decreased when dexamethasone was added to cell cultures prior to
irradiation. These results were confirmed by Annexin V staining at
Dexamethasone-mediated inhibition of apoptosis 1711
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Figure 1 Northern blot analysis of HPV 18 E6/E7 mRNA 48 h after
treatment (A). In C4-1 cells, dexamethasone increases the E6/E7 mRNA
level alone or in combination with irradiation by five- to sevenfold over that of
control or irradiated cells as determined by densitometry. In SW 756 cells,
expression of HPV E6/E7 mRNA was repressed twofold in the presence of
dexamethasone alone or in combination with irradiation. Three separate
experiments were performed and the standard error of the mean
densitometric units is shown (B). Equal loading of RNA is demonstrated by
the ribosomal RNA 18S and 28S bands. (HPV E6/E7 mRNA was normalized
against the ribosomal RNA to determine the fold increase/decrease in
expression.) The major HPV 18 transcripts are shown for C4-1 (®) and
SW756 (Ü)1712 MC Kamradt et al
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Figure 2 Percent apoptosis in HPV-positive (A, B C4-1; C, D SW756) or HPV-negative (E, F C33a) cell lines as assessed by morphology over 4 days (A, C, E)
and Annexin V staining at 4 days after treatment (B, D, F). The standard error of the mean of at least three separate experiments is shown. Radiation-induced
apoptosis decreased in the C4-1 cells by the addition of 1 mM dexamethasone prior to irradiation. In C4-1 cells, Annexin V staining showed that at 4 days
following treatment, the dexamethasone-mediated inhibition of apoptosis was significant (*P < 0.01, radiation versus radiation plus dexamethasone). In contrast,
dexamethasone had no effect on the apoptosis of cells in which dexamethasone repressed HPV E6/E7 (SW 756) or cells which lack HPV. Cells are treated as
follows: control (n); dexamethasone (l); radiation (n n); radiation+dexamethasone (l l)4 days post-treatment and the dexamethasone-mediated inhibition
of apoptosis was found to be significant (P < 0.01) (Figure 2B). In
contrast, dexamethasone did not alter the ability of the SW756
cells (in which dexamethasone represses the HPV E6/E7 genes) to
undergo apoptosis following irradiation as cells irradiated alone or
in the presence of dexamethasone displayed similar levels of apop-
tosis over a 4-day period (Figure 2 C, D). The C-33a cells which
lack HPV also exhibited no change in the level of radiation-
induced apoptosis when cells were pretreated with dexamethasone
(Figure 2 E, F).
In order to assess a biochemical correlate of apoptosis in our
system, the presence of internucleosomal cleavage was determined
using the DNA ‘laddering’ assay. As a result of cell death by apop-
tosis, DNA is cleaved into multiples of 200 basepair fragments
which correspond to cleavage of internucleosomal DNA. Analysis
by gel electrophoresis revealed that DNA from apoptotic cells
exhibited a characteristic ladder. By 4 days following irradiation,
the C4-1 cells showed clear DNA laddering when cells were irra-
diated, but this effect was almost completely abrogated in cells that
were treated with dexamethasone prior to irradiation. In contrast,
dexamethasone had no effect on radiation-induced DNA fragmen-
tation in either the SW756 or the C33-a cell lines (Figure 3 A–C).
Effect of dexamethasone on p53 protein levels
Despite HPV infection of human cervical keratinocytes, p53 is
capable of transactivating its target genes GADD45 and p21,
which are involved in DNA repair processes or activation of the
G1/S checkpoint (Butz et al, 1995, 1999). Therefore, within the
HPV-containing cervical cell lines studied here, the p53 pathway is
likely to be functional and may be regulated by radiation and/or
dexamethasone treatment. In order to elucidate the molecular
mechanism by which the C4-1 cells escape radiation-induced
apoptosis in the presence of dexamethasone, we determined the
effect of glucocorticoid treatment on the level of p53 protein
expression in these cells (Figure 4A). As analysed by flow cytom-
etry, C4-1 cells treated with 1 mM dexamethasone alone exhibited
decreased expression of p53 protein for up to 4 days in comparison
to control cells. While irradiated cells showed an approximately
Dexamethasone-mediated inhibition of apoptosis 1713
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Figure 3 Apoptosis was determined by DNA fragmentation analysis 4 days following treatment in C4-1 (A), SW756 (B) and C33-a (C) cells. Dexamethasone
had no effect on radiation-induced apoptosis in cells that lack HPV (C33-a) or in cells in which HPV E6/E7 transcription is repressed following treatment with
glucocorticoids (SW756). However, a marked inhibition of DNA fragmentation was observed in C4-1 cells irradiated in the presence of dexamethasone. Cells
were untreated (C), treated with 6 Gy irradiation (R) or 1 mM dexamethasone (D) or both radiation and dexamethasone (D+R) as indicated; M: marker
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Figure 4 Levels of p53 protein were determined in C4-1 cells by flow
cytometry (A) following treatment with dexamethasone (l), radiation (n) or
both dexamethasone and irradiation (s) (The error bars are the standard
error of the mean of four separate experiments.) Protein levels are
expressed as a percent of control. By 24 h following treatment,
dexamethasone decreased while radiation increased p53 by approximately
40% respectively. p53 levels remained near control values followed by
dexamethasone and radiation treatment. These data were confirmed at 48 h
following treatment by Western blot analysis (B)50% increase in p53 expression by 48 h after irradiation, cells irra-
diated in the presence of dexamethasone exhibited p53 expression
similar to that of control cells, an effect intermediate between that
observed with either dexamethasone or irradiation alone. To
confirm the specificity of the flow cytometry data, p53 protein was
also analysed by Western blot at 24 h following treatment which
revealed the same trend in p53 expression (Figure 4B). C-33a cells
possess mutant p53 protein which is highly overexpressed as
determined by flow cytometry and Western blot analysis (data not
shown) while SW756 cells cultured in dexamethasone exhibited
decreased HPV E6/E7 mRNA and increased p53 levels as
determined by Western blot (Von Knebel Doeberitz et al, 1994).
Therefore, it appears that loss of p53 expression due to dexa-
methasone-mediated up-regulation of HPV E6/E7 is associated
with decreased apoptosis following g irradiation.
Analysis of p21 mRNA expression
The data presented indicate that exposure to dexamethasone
modifies both upstream (p53) and downstream (fragmentation)
components of the apoptotic pathway in C4-1 cells. In order to
determine whether p53 is functional, p21, a cyclin-dependent
kinase inhibitor which is transcriptionally regulated by p53, was
examined (el-Deiry et al, 1993; Harper et al, 1993). It was found
that p21 mRNA is regulated in the same manner as p53 (Figure 5),
which is consistent with the proposal that steroid-mediated
changes in the apoptotic pathway involve p53 and its downstream
targets.
DISCUSSION
Our data provide support for the notion that in HPV-transformed
cells, access to apoptosis appears dependent upon p53 function.
The p53 protein facilitates apoptotic cell death in response to DNA
damaging agents such as radiation or chemotherapeutic drugs
(Yonish-Rouach et al, 1991; Shaw et al, 1992). Since p53 is an
important regulator of apoptosis, changes in p53 status in HPV-
infected cells may alter access to programmed cell death. Here,
dexamethasone treatment prior to irradiation resulted in a signifi-
cant decrease in the level of radiation-induced apoptosis and p53
protein in C4-1 cells, concomitant with an increase in HPV E6/E7
mRNA. For this reason, dexamethasone is proposed to contribute
to a decrease in apoptosis through E6-mediated degradation of p53
in C4-1 cells. In contrast, neither the HPV-negative C-33a cells,
nor the SW756 cells that repress HPV E6/E7 and induce p53 in the
presence of dexamethasone, exhibited diminished apoptosis
following irradiation and steroid treatment (Von Knebel Doeberitz
et al, 1994).
Various studies demonstrating that HPV E6 and E7 can alter
access to apoptosis support our findings that dexamethasone-
mediated up-regulation of E6/E7 results in inhibition of apoptosis.
While both E6 and E6/E7 have been shown to abrogate p53 depen-
dent cell cycle arrest (Kessis et al, 1993; Thomas et al, 1996; Wang
et al, 1996; Hickman et al, 1997), the viral proteins differ in their
abilities to promote or inhibit apoptosis. In transgenic mice, E7
induced lens cell proliferation and apoptosis dependent upon its
association with Rb and Rb-like proteins while apoptosis-like
DNA degradation was reduced in E6 ´ E7 or inhibited in E6 trans-
genic mice (Pan and Griep, 1994, 1995). Also, p53-dependent and
-independent apoptosis have been demonstrated in Rb knockout
mice (Morgenbesser et al, 1994) which suggests that loss of Rb is
the primary function of E7 that enhances apoptosis. E7 has been
shown to prime or sensitize cells to apoptosis in response to an
appropriate stimulus (Puthenveettil et al, 1996; Iglesias et al, 1998;
Stoppler et al, 1998). While E7-transduced keratinocytes exhibited
increased apoptosis and p53 levels, cells that express E6 or E6/E7
fail to undergo apoptosis following DNA damage suggesting that
E6 has compromised p53 function by ubiquitin-dependent
degradation (Puthenveettil et al, 1996; Thomas et al, 1996). Taken
together, these data support the present study by showing that
through inactivation of p53, up-regulation of E6 or E6/E7 can
abrogate apoptosis during development or following DNA
damage.
Mutation of p53 can influence the ability of radiation to induce
apoptosis, thus p53 appeared to be necessary for radiation-induced
programmed cell death (Clarke et al, 1993; Lowe et al, 1993).
However, it has been shown that apoptosis occurs in cells with
wild-type p53 and in cells which possess mutations in, or lack p53
following irradiation (Radford, 1994; Strasser et al, 1994; Bracey
et al, 1995). Despite HPV infection of human cervical
keratinocytes, p53 is capable of transactivation of its downstream
target genes GADD45 and p21 as shown by others (Butz et al,
1995, 1999) and p21, as shown here. Therefore, in HPV-infected
cervical epithelial cells, the presence of the E6 protein may not
completely abrogate the apoptotic pathway through loss of p53 as
cells still activate p53-dependent genes. These studies support the
presence of a functional p53 in our system as we have demon-
strated that regulation of p53 and p21 correspond to observed
changes in apoptotic cell death.
Glucocorticoids have been shown to readily cause apoptosis in
cells of the lymphoid system. Thymocytes from p53 knockout
mice still access apoptosis in response to dexamethasone, thus,
apoptosis in response to glucocorticoids occurs independent of
p53 (Clarke et al, 1993; Lowe et al, 1993). However, through
mechanisms which remain unclear, dexamethasone has also been
shown to protect cells from apoptosis in various systems.
Dexamethasone affords cytoprotection to malignant but not
untransformed glial cells, which has been correlated with a p53-
independent increase in p21 protein (Naumann et al, 1998). In
contrast, dexamethasone protected mouse embryonic fibroblasts
from drug-mediated cytotoxicity but only in cells which were
deficient in p21. Thus, the mechanism by which dexamethasone
1714 MC Kamradt et al
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Figure 5 Northern blot analysis of p21 mRNA was performed following
treatment with radiation, dexamethasone or both at 48 h following treatment.
In comparison to untreated cells, p21 mRNA increased following irradiation
while dexamethasone treatment led to decreased p21 mRNA. Cells that were
irradiated in the presence of dexamethasone exhibited decreased p21 in
comparison to irradiated cells. p21 mRNA was normalized against the
28/18S ribosomal RNAprotects cells from apoptosis appears to be cell type-specific and
may or may not involve p53 and its downstream targets. The data
presented here support a clear mechanism for dexamethasone-
dependent inhibition of apoptosis involving modulation of HPV
E6 and p53 in cervical carcinoma cells.
Steroid-mediated inhibition of apoptosis in human cervical
carcinoma cells may have clinical impact. Like dexamethasone,
progesterone has been shown to activate HPV gene expression by
binding to the same GRE. Progesterone-induced elevation in viral
RNA was blocked by the progestin antagonist RU486 (Mittal et al,
1993). Therefore, endogenous levels of steroids and those existing
as a consequence of taking oral contraceptives may induce HPV
gene transcription and contribute to tumour progression (Stern et
al, 1977; Zur Hausen, 1991). Since endogenous or administered
hormones can activate GRE-driven increase in HPV transcription,
HPV-positive tumours may also be radioresistant and less suscep-
tible to apoptosis following irradiation. If true, the administration
of steroid/receptor antagonists, such as RU486, might be benefi-
cial prior to radiotherapy to enhance tumour cell death through the
apoptotic pathway.
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